U2AF1 and non-small cell lung carcinoma: Indeed, when wild type U2AF35 was knocked out in heterozygous NSCLC cell lines, cell proliferation was abrogated completely, confirming that mutant U2AF35 could not compensate for loss of the wild type protein.